Xvivo Perfusion Aktiebolag — Short Positions & Disclosures
Regulatory net short position disclosures over time
As of 17 Apr 2026, 7 institutions have disclosed net short positions in Xvivo Perfusion Aktiebolag totalling 7.18% of issued share capital. The largest disclosed short seller is Marchant MC Ltd at 1.60%. Positions are publicly disclosed under UK FCA rules once they reach or exceed 0.5% of issued share capital.
Last updated
Xvivo Perfusion Aktiebolag | Short Positions Over Time
SE0004840718Short positions must be disclosed when they reach or exceed 0.5% of issued share capital.
Current Short Positions
All disclosed positions as of the latest report date
| Holder | Net Short % | Position Date | Position Value |
|---|---|---|---|
Winton Capital Management Limited | 0.59% | 17 Apr 2026 | Locked |
Acadian Asset Management LLC | 1.34% | 16 Apr 2026 | Locked |
JPMorgan Asset Management (UK) Ltd | 1.39% | 16 Apr 2026 | Locked |
Marchant MC Ltd | 1.60% | 16 Apr 2026 | Locked |
AQR Capital Management LLC | 0.70% | 08 Apr 2026 | Locked |
Citadel Advisors LLC | 0.96% | 01 Apr 2026 | Locked |
D E Shaw Co LP | 0.60% | 20 Mar 2026 | Locked |
Data source: UK Financial Conduct Authority short position disclosures, plus equivalent disclosures from EU regulators (BaFin, CONSOB, AFM, Finansinspektionen). View FCA short selling rules.
Net short percentage represents the percentage of issued share capital held short. Positions must be publicly disclosed when they reach or exceed the 0.5% regulatory threshold. Read the methodology.